![www.macrumors.com](https://images.macrumors.com/t/j9lfHW_qnx4RSnqtw-9s8ujUXyo=/2500x/article-new/2023/09/Apple-Watch-Ultra-2-hero-feature-white.jpg)
Apple Pausing Sales of Apple Watch Series 9 and Ultra 2 in U.S. Due to Patent Dispute
Apple today said it will be pausing sales of the Apple Watch Series 9 and Apple Watch Ultra 2 in the U.S. later this week due to an ongoing patent...
![www.macrumors.com](https://images.macrumors.com/images-new/favicon-32x32.png)
Since 2020 a company called Masimo has accused Apple of poaching employees and stealing trade secrets for the blood oxygen sensing features on Apple Watch. The ITC has ruled for a sale ban in October and has given time until December 25 for President Biden to overrule the decision. It's looking like this is not going to happen.
Apple's statement in full:
A Presidential Review Period is in progress regarding an order from the U.S. International Trade Commission on a technical intellectual property dispute pertaining to Apple Watch devices containing the Blood Oxygen feature. While the review period will not end until December 25, Apple is preemptively taking steps to comply should the ruling stand. This includes pausing sales of the Apple Watch Series 9 and Apple Watch Ultra 2 from Apple.com starting December 21, and from Apple retail locations after December 24. The decision does not impact sales of the devices in other countries at this time.
Apple's teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features. Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers.
Should the order stand, Apple will continue to take all measures to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the U.S. as soon as possible.